Skip to main content
Top
Published in: BMC Medical Informatics and Decision Making 1/2011

Open Access 01-12-2011 | Research article

An algorithm to identify patients with treated type 2 diabetes using medico-administrative data

Authors: Laurence M Renard, Valery Bocquet, Gwenaelle Vidal-Trecan, Marie-Lise Lair, Sophie Couffignal, Claudine Blum-Boisgard

Published in: BMC Medical Informatics and Decision Making | Issue 1/2011

Login to get access

Abstract

Background

National authorities have to follow the evolution of diabetes to implement public health policies. An algorithm was developed to identify patients with treated type 2 diabetes and estimate its annual prevalence in Luxembourg using health insurance claims when no diagnosis code is available.

Methods

The DIABECOLUX algorithm was based on patients' age as well as type and number of hypoglycemic agents reimbursed between 1995 and 2006. Algorithm validation was performed using the results of a national study based on medical data. Sensitivity, specificity and predictive values were estimated.

Results

The sensitivity of the DIABECOLUX algorithm was found superior to 98.2%. Between 2000 and 2006, 22,178 patients were treated for diabetes in Luxembourg, among whom 21,068 for type 2 diabetes (95%). The prevalence was estimated at 3.79% in 2006 and followed an increasing linear trend during the period. In 2005, the prevalence was low for young age classes and increased rapidly from 40 to 70 for male and 80 for female, reaching a peak of, respectively 17.0% and 14.3% before decreasing.

Conclusions

The DIABECOLUX algorithm is relevant to identify treated type 2 diabetes patients. It is reproducible and should be transferable to every country using medico-administrative databases not including diagnosis codes. Although undiagnosed patients and others with lifestyle recommendations only were not considered in this study, this algorithm is a cheap and easy-to-use tool to inform health authorities. Further studies will use this tool with the aim of improving the quality of health care dedicated to diabetic patients in Luxembourg.
Appendix
Available only for authorised users
Literature
1.
go back to reference Price HC, Clarke PM, Gray AM, Holman RR: Life Expectancy in Individuals With Type 2 Diabetes: Implications for Annuities. Med Decis Making. 2010, 30 (3): 409-414. 10.1177/0272989X09349960.CrossRefPubMed Price HC, Clarke PM, Gray AM, Holman RR: Life Expectancy in Individuals With Type 2 Diabetes: Implications for Annuities. Med Decis Making. 2010, 30 (3): 409-414. 10.1177/0272989X09349960.CrossRefPubMed
2.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27 (5): 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27 (5): 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed
3.
go back to reference Bell JI, Hockasay TDR: Diabetes Mellitus. Oxford Textbook of medicine. Edited by: Weatherall DJ,Ledingham JGG, Warrell DA. 1996, 2: 1448-1504. 3 Bell JI, Hockasay TDR: Diabetes Mellitus. Oxford Textbook of medicine. Edited by: Weatherall DJ,Ledingham JGG, Warrell DA. 1996, 2: 1448-1504. 3
4.
go back to reference Guttmann A, Nakhla M, Henderson M, To T, Daneman D, Cauch-Dudek K, Wang X, Lam K, Hux J: Validation of a health administrative data algorithm for assessing the epidemiology of diabetes in Canadian children. Pediatr Diabetes. 2009, 11 (2): 122-128. 10.1111/j.1399-5448.2009.00539.x.CrossRefPubMed Guttmann A, Nakhla M, Henderson M, To T, Daneman D, Cauch-Dudek K, Wang X, Lam K, Hux J: Validation of a health administrative data algorithm for assessing the epidemiology of diabetes in Canadian children. Pediatr Diabetes. 2009, 11 (2): 122-128. 10.1111/j.1399-5448.2009.00539.x.CrossRefPubMed
5.
go back to reference Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002, 25 (3): 512-516. 10.2337/diacare.25.3.512.CrossRefPubMed Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002, 25 (3): 512-516. 10.2337/diacare.25.3.512.CrossRefPubMed
6.
go back to reference Solberg LI, Engebretson KI, Sperl-Hillen JM, Hroscikoski MC, O'Connor PJ: Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression. Am J Med Qual. 2006, 21 (4): 238-245. 10.1177/1062860606288243.CrossRefPubMed Solberg LI, Engebretson KI, Sperl-Hillen JM, Hroscikoski MC, O'Connor PJ: Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression. Am J Med Qual. 2006, 21 (4): 238-245. 10.1177/1062860606288243.CrossRefPubMed
7.
go back to reference Ng E, Dasgupta K, Johnson JA: An algorithm to differentiate diabetic respondents in the Canadian Community Health Survey. Health Rep. 2008, 19 (1): 71-79.PubMed Ng E, Dasgupta K, Johnson JA: An algorithm to differentiate diabetic respondents in the Canadian Community Health Survey. Health Rep. 2008, 19 (1): 71-79.PubMed
9.
go back to reference Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010, 87 (1): 4-14. 10.1016/j.diabres.2009.10.007.CrossRefPubMed Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010, 87 (1): 4-14. 10.1016/j.diabres.2009.10.007.CrossRefPubMed
10.
go back to reference Louazel V, Perquin M, Couffignal S, Rott C, Michel G, De Beaufort C, Lair ML: Le diabète au Luxembourg. Etat de la situation à partir de données médico-administratives. Enjeux Santé. 2008 Louazel V, Perquin M, Couffignal S, Rott C, Michel G, De Beaufort C, Lair ML: Le diabète au Luxembourg. Etat de la situation à partir de données médico-administratives. Enjeux Santé. 2008
13.
go back to reference Lecomte P, Romon I, Fosse S, Simon D, Fagot-Campagna A: Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001. Diabetes Metab. 2008, 34 (3): 219-226. 10.1016/j.diabet.2007.11.005.CrossRefPubMed Lecomte P, Romon I, Fosse S, Simon D, Fagot-Campagna A: Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001. Diabetes Metab. 2008, 34 (3): 219-226. 10.1016/j.diabet.2007.11.005.CrossRefPubMed
14.
go back to reference Marant C, Romon I, Fosse S, Weill A, Simon D, Eschwege E, Varroud-Vial M, Fagot-Campagna A: French medical practice in type 2 diabetes: the need for better control of cardiovascular risk factors. Diabetes Metab. 2008, 34 (1): 38-45.CrossRefPubMed Marant C, Romon I, Fosse S, Weill A, Simon D, Eschwege E, Varroud-Vial M, Fagot-Campagna A: French medical practice in type 2 diabetes: the need for better control of cardiovascular risk factors. Diabetes Metab. 2008, 34 (1): 38-45.CrossRefPubMed
15.
go back to reference Alkerwi A, Sauvageot N, Couffignal S, Albert A, Lair ML, Guillaume M: Comparison of participants and non-participants to the ORISCAV-LUX population-based study on cardiovascular risk factors in Luxembourg. BMC Med Res Methodol. 2010, 10: 80-10.1186/1471-2288-10-80.CrossRefPubMedPubMedCentral Alkerwi A, Sauvageot N, Couffignal S, Albert A, Lair ML, Guillaume M: Comparison of participants and non-participants to the ORISCAV-LUX population-based study on cardiovascular risk factors in Luxembourg. BMC Med Res Methodol. 2010, 10: 80-10.1186/1471-2288-10-80.CrossRefPubMedPubMedCentral
16.
go back to reference Alkerwi A, Sauvageot N, Donneau AF, Lair ML, Couffignal S, Beissel J, Delagardelle C, Wagener Y, Albert A, Guillaume M: First nationwide survey on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-LUX). BMC Public Health. 2010, 10: 468-10.1186/1471-2458-10-468.CrossRefPubMedPubMedCentral Alkerwi A, Sauvageot N, Donneau AF, Lair ML, Couffignal S, Beissel J, Delagardelle C, Wagener Y, Albert A, Guillaume M: First nationwide survey on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-LUX). BMC Public Health. 2010, 10: 468-10.1186/1471-2458-10-468.CrossRefPubMedPubMedCentral
19.
go back to reference InVS: Prévalence du diabète en 2007. Database broken down by age and sex edn. 2007, Saint Maurice (France) InVS: Prévalence du diabète en 2007. Database broken down by age and sex edn. 2007, Saint Maurice (France)
20.
go back to reference Kusnik-Joinville O, Weill A, Salanave B, Ricordeau P, Allemand H: Prevalence and treatment of diabetes in France: trends between 2000 and 2005. Diabetes Metab. 2008, 34 (3): 266-272. 10.1016/j.diabet.2008.01.005.CrossRefPubMed Kusnik-Joinville O, Weill A, Salanave B, Ricordeau P, Allemand H: Prevalence and treatment of diabetes in France: trends between 2000 and 2005. Diabetes Metab. 2008, 34 (3): 266-272. 10.1016/j.diabet.2008.01.005.CrossRefPubMed
23.
go back to reference Fleming DM, Schellevis FG, Van Casteren V: The prevalence of known diabetes in eight European countries. Eur J Public Health. 2004, 14 (1): 10-14. 10.1093/eurpub/14.1.10.CrossRefPubMed Fleming DM, Schellevis FG, Van Casteren V: The prevalence of known diabetes in eight European countries. Eur J Public Health. 2004, 14 (1): 10-14. 10.1093/eurpub/14.1.10.CrossRefPubMed
24.
go back to reference Hauner H: Prevalence of diabetes mellitus and quality of care in Hesse, Germany, 1998-2004. Dtsch Arztebl. 2007, 104 (41): 2799-2805. Hauner H: Prevalence of diabetes mellitus and quality of care in Hesse, Germany, 1998-2004. Dtsch Arztebl. 2007, 104 (41): 2799-2805.
25.
go back to reference Ubink-Veltmaat LJ, Bilo HJ, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B: Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in The Netherlands (ZODIAC-1). Eur J Epidemiol. 2003, 18 (8): 793-800. 10.1023/A:1025369623365.CrossRefPubMed Ubink-Veltmaat LJ, Bilo HJ, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B: Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in The Netherlands (ZODIAC-1). Eur J Epidemiol. 2003, 18 (8): 793-800. 10.1023/A:1025369623365.CrossRefPubMed
27.
go back to reference Kusnik-Joinville O, Weill A, Ricordeau P, Allemand H: Treated diabetes in France in 2007: a prevalence rate close to 4% and increasing geographic disparities. Bulletin Epidémiologique Hebdomadaire. 2008, 43: 409-413. Kusnik-Joinville O, Weill A, Ricordeau P, Allemand H: Treated diabetes in France in 2007: a prevalence rate close to 4% and increasing geographic disparities. Bulletin Epidémiologique Hebdomadaire. 2008, 43: 409-413.
28.
go back to reference Weill A, Kusnik-joinville O, Simon D, Tuppin P, Ricordeau P, Allemand H: People with diabetes in France: 3.95% prevalence rate and a 32% hospitalization rate in 2007. International Diabetes Federation (IDF) 20th World Diabetes Congress. Montreal, Canada. 2009 Weill A, Kusnik-joinville O, Simon D, Tuppin P, Ricordeau P, Allemand H: People with diabetes in France: 3.95% prevalence rate and a 32% hospitalization rate in 2007. International Diabetes Federation (IDF) 20th World Diabetes Congress. Montreal, Canada. 2009
Metadata
Title
An algorithm to identify patients with treated type 2 diabetes using medico-administrative data
Authors
Laurence M Renard
Valery Bocquet
Gwenaelle Vidal-Trecan
Marie-Lise Lair
Sophie Couffignal
Claudine Blum-Boisgard
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Medical Informatics and Decision Making / Issue 1/2011
Electronic ISSN: 1472-6947
DOI
https://doi.org/10.1186/1472-6947-11-23

Other articles of this Issue 1/2011

BMC Medical Informatics and Decision Making 1/2011 Go to the issue